Pemigatinib is a treatment that the FDA has approved. It’s used for cholangiocarcinoma, a type of liver cancer, especially when there’s a FGFR2 fusion. It’s available as a pill, and you can get it in doses of 4.5 mg, 9 mg, or 13.5 mg.
You’re supposed to take one 13.5 mg pill every day for the first 14 days of every 21-day period. Each box has 14 tablets in it.
